Home/Filings/4/0001209191-23-055787
4//SEC Filing

LEPORE PATRICK G 4

Accession 0001209191-23-055787

CIK 0001566044other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 5:03 PM ET

Size

5.3 KB

Accession

0001209191-23-055787

Insider Transaction Report

Form 4
Period: 2023-11-15
Transactions
  • Purchase

    Common Stock

    2023-11-15$3.91/sh+13,000$50,77836,472 total
Footnotes (1)
  • [F1]The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $3.57 to $4.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1
  • filerCIK 0001055404

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 5:03 PM ET
Size
5.3 KB